Evaluation of the Diagnostic Performance of Electrical Impedance Tomography to Detect Situations at Risk of Lesions Induced by Conventional Mechanical Ventilation in ARDS
NCT ID: NCT02896673
Last Updated: 2018-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3 participants
INTERVENTIONAL
2012-07-17
2015-01-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This technique also allows a regional analysis, allowing the complexity of the spatial distribution of ARDS pulmonary lesions to be understood. The hypothesis is that EIT is a reliable method to detect at-risk situations of lesions induced by mechanical ventilation among patients with ARDS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrical Impedance Tomography-Based Prognostic Model for ARDS
NCT06967207
Combining Electrical Impedance Tomography and Thoracic Ultrasound Toinvestigate Dynamic Changes
NCT06958770
Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome
NCT04603755
Pressure Opening With Electrical Impedance Tomography
NCT05825534
Early PP Monitored by EIT in Patients With ARDS
NCT05822869
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ventilatory conditions and measures with scanner and EIT
The patient is installed on the scanner bed, EIT electrodes are connected to the acquisition device of the EIT signal.
Esophageal pressure signals, pressure and flow in the airways will be acquired continuously
ventilatory conditions and measures with scanner and EIT
Different ventilatory conditions are studied and measures are acquired with scanner and EIT
Time A: measure under basal conditions (TVbasal=6ml/kg of predicted weight), basal PEP, basal inspiratory time / total time = 30%)
Time B: different PEP are applied for 4 minutes: 5, 10, 15, 20 cm of H2O conserving the basal TV
Time C: different TV are applied for 4 minutes: 4, 7, 10 ml/kg of predicted weight conserving the basal PEP and the basal inspiratory time
Time D: recruitment in continuous positive airway pressure at 45 cm of H2O is performed for 30 seconds
Time E: return to adjustment period A
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ventilatory conditions and measures with scanner and EIT
Different ventilatory conditions are studied and measures are acquired with scanner and EIT
Time A: measure under basal conditions (TVbasal=6ml/kg of predicted weight), basal PEP, basal inspiratory time / total time = 30%)
Time B: different PEP are applied for 4 minutes: 5, 10, 15, 20 cm of H2O conserving the basal TV
Time C: different TV are applied for 4 minutes: 4, 7, 10 ml/kg of predicted weight conserving the basal PEP and the basal inspiratory time
Time D: recruitment in continuous positive airway pressure at 45 cm of H2O is performed for 30 seconds
Time E: return to adjustment period A
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalised in the medical resuscitation department of the Croix Rousse hospital, Lyon, Fr
* With ARDS according to the 1994 American-European Consensus Conference
* Duration of ARDS less than 96 hours
* With invasive mechanical ventilation
* With sedative and analgesic treatment for adaptation of the respirator with or without neuromuscular blocking agents
* Consent obtained from patient family
* Indication for thoracic scanner as judged by the physician in charge of the patient
Exclusion Criteria
* severe hypoxemia defined as sever by arterial blood pressure/fraction of inspired oxygen (PaO2/ FiO2) below 100 mm Hg in dorsal decubitus position
* uncontrolled respiratory acidosis, defined by a pH below 7.25, despite an increase of respiratory frequency up to 35/min and a tidal volume up to 8 mL/kg of predicted weight
* respiratory system plateau pressure higher than 30 cm H2O, with a tidal volume below or equal to 6 mL/kg of predicted weight.
* Contraindication for transport to the radiology department
* uncontrolled hemodynamic instability defined by a mean arterial blood pressure below 65 mm Hg, despite use of antihypotensive agents
* patient requiring continuous dialysis without possibility for disconnection for reason of uncontrolled metabolic acidosis (pH\<7.20).
* Without reliable monitoring during transport of the patient to the radiology department
* absence of invasive arterial pressure measurement
* unreliable measurement of arterial saturation in oxygen (SpO2) defined by a perfusion index below 0.5.
* Intracranial hypertension
* Impossible to apply EIT electrodes on the thorax of the patient (burns, dressings, …)
* Undrained pneumothorax or bronchopleural fistula
* Scanner unavailable for the study (broken down, overloaded program, …)
* Contraindication esophageal balloon catheter
* Known or suspected esophageal disease (tumor, esophageal varices, esophagitis, diverticulum, ...)
* Latex allergy
* Patient previously included in the study
* Vulnerable persons (as defined in laws L1121-5 to L1121-7, L1121-8 and L1122-1-2
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital de la Croix Rousse
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-642
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.